CRD-4730, CRD-4730 matching placebo
CRD-4730-202
Phase 2 small_molecule active
Quick answer
CRD-4730, CRD-4730 matching placebo for Catecholaminergic Polymorphic Ventricular Tachycardia is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Catecholaminergic Polymorphic Ventricular Tachycardia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active